Lantheus Holdings, Inc. Inventory Write-down
Lantheus Holdings, Inc. (LNTH) reported Inventory Write-down of $1.99 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-06
- Lantheus Holdings, Inc. inventory write-down for the quarter ending 2026-06-30 was $454.00K, a 80.38% decline year-over-year.
- Lantheus Holdings, Inc. inventory write-down for the quarter ending 2026-03-31 was $1.54M.
- Lantheus Holdings, Inc. inventory write-down for the quarter ending 2025-12-31 was -$667.00K.
- Lantheus Holdings, Inc. inventory write-down for the quarter ending 2025-09-30 was $1.93M.
- Lantheus Holdings, Inc. inventory write-down for fiscal 2025 was $2.20M.
- Lantheus Holdings, Inc. inventory write-down for fiscal 2024 was -$904.00K, a 111.42% decline from fiscal 2023.
- Lantheus Holdings, Inc. inventory write-down for fiscal 2023 was $7.91M, a 10.76% increase from fiscal 2022.
- Lantheus Holdings, Inc. inventory write-down for fiscal 2022 was $7.14M, a 76.12% increase from fiscal 2021.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-06-30 | $454.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.99M 10-Q · filed 2026-08-06 | $1.32M derived: sum of 3 quarters · filed 2026-08-06 | $3.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.54M 10-Q · filed 2026-05-07 | $870.00K derived: sum of 2 quarters · filed 2026-05-07 | $2.80M derived: sum of 3 quarters · filed 2026-05-07 | $5.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.27M derived: sum of 2 quarters · filed 2026-02-26 | $3.58M derived: sum of 3 quarters · filed 2026-08-06 | $2.20M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.25M derived: sum of 2 quarters · filed 2026-08-06 | $2.87M 10-Q · filed 2025-11-06 | $1.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $936.00K 10-Q · filed 2026-08-06 | -$706.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.38M 10-Q · filed 2026-05-07 | -$3.02M derived: sum of 2 quarters · filed 2026-05-07 | -$4.21M derived: sum of 3 quarters · filed 2026-05-07 | -$5.04M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.83M derived: sum of 2 quarters · filed 2026-02-26 | -$3.66M derived: sum of 3 quarters · filed 2026-02-26 | -$904.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.02M derived: sum of 2 quarters · filed 2025-11-06 | $738.00K 10-Q · filed 2025-11-06 | $3.40M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$832.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.93M 10-Q · filed 2025-08-06 | $4.59M derived: sum of 3 quarters · filed 2026-02-26 | $6.66M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.76M 10-Q · filed 2025-05-07 | $5.42M derived: sum of 2 quarters · filed 2026-02-26 | $7.49M derived: sum of 3 quarters · filed 2026-02-26 | $9.99M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.74M derived: sum of 2 quarters · filed 2026-02-26 | $7.23M derived: sum of 3 quarters · filed 2026-02-26 | $7.91M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $4.57M derived: sum of 2 quarters · filed 2024-11-06 | $5.25M 10-Q · filed 2024-11-06 | $7.42M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $3.18M 10-Q · filed 2024-07-31 | $5.34M derived: sum of 3 quarters · filed 2025-02-26 | $7.14M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $680.00K 10-Q · filed 2024-05-02 | $2.85M derived: sum of 2 quarters · filed 2025-02-26 | $4.64M derived: sum of 3 quarters · filed 2025-02-26 | $5.31M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $3.96M derived: sum of 2 quarters · filed 2025-02-26 | $4.63M derived: sum of 3 quarters · filed 2025-02-26 | $7.14M 10-K · filed 2025-02-26 |
| 2022-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.46M derived: sum of 2 quarters · filed 2023-11-02 | $4.98M 10-Q · filed 2023-11-02 | $6.72M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $666.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.19M 10-Q · filed 2023-08-03 | $4.92M derived: sum of 3 quarters · filed 2024-02-22 | $5.20M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $2.52M 10-Q · filed 2023-05-04 | $4.26M derived: sum of 2 quarters · filed 2024-02-22 | $4.54M derived: sum of 3 quarters · filed 2024-02-22 | $5.18M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $2.02M derived: sum of 2 quarters · filed 2024-02-22 | $2.66M derived: sum of 3 quarters · filed 2024-02-22 | $4.06M 10-K · filed 2024-02-22 |
| 2021-09-30 | $278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $922.00K derived: sum of 2 quarters · filed 2022-11-03 | $2.32M 10-Q · filed 2022-11-03 | $2.81M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $644.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.04M 10-Q · filed 2022-08-04 | $2.53M derived: sum of 3 quarters · filed 2023-02-23 | $2.87M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.40M 10-Q · filed 2022-04-29 | $1.89M derived: sum of 2 quarters · filed 2023-02-23 | $2.23M derived: sum of 3 quarters · filed 2023-02-23 | $3.31M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $834.00K derived: sum of 2 quarters · filed 2023-02-23 | $1.92M derived: sum of 3 quarters · filed 2023-02-23 | $2.37M 10-K · filed 2023-02-23 |
| 2020-09-30 | $339.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.42M derived: sum of 2 quarters · filed 2021-11-04 | $1.87M 10-Q · filed 2021-11-04 | $2.02M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $1.53M 10-Q · filed 2021-07-28 | $1.68M derived: sum of 3 quarters · filed 2022-02-24 | $2.40M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $449.00K 10-Q · filed 2021-05-04 | $601.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.32M derived: sum of 3 quarters · filed 2022-02-24 | $1.79M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $874.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.34M derived: sum of 3 quarters · filed 2022-02-24 | $1.85M 10-K · filed 2022-02-24 |
| 2019-09-30 | $722.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.19M derived: sum of 2 quarters · filed 2020-11-05 | $1.70M 10-Q · filed 2020-11-05 | $2.10M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $466.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $977.00K 10-Q · filed 2020-07-31 | $1.38M derived: sum of 3 quarters · filed 2021-02-25 | $1.89M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $511.00K 10-Q · filed 2020-04-30 | $916.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.43M derived: sum of 3 quarters · filed 2021-02-25 | $2.17M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $405.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $916.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.66M derived: sum of 3 quarters · filed 2021-02-25 | $2.88M 10-K · filed 2021-02-25 |
| 2018-09-30 | $511.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $1.25M derived: sum of 2 quarters · filed 2019-10-31 | $2.47M 10-Q · filed 2019-10-31 | $2.68M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $739.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $1.96M 10-Q · filed 2019-07-25 | $2.17M derived: sum of 3 quarters · filed 2020-02-25 | $2.44M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $1.22M 10-Q · filed 2019-04-30 | $1.43M derived: sum of 2 quarters · filed 2020-02-25 | $1.71M derived: sum of 3 quarters · filed 2020-02-25 | $2.15M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $485.00K derived: sum of 2 quarters · filed 2020-02-25 | $930.00K derived: sum of 3 quarters · filed 2020-02-25 | $1.22M 10-K · filed 2020-02-25 |
| 2017-09-30 | $272.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $717.00K derived: sum of 2 quarters · filed 2018-10-30 | $1.00M 10-Q · filed 2018-10-30 | $1.36M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-06-30 | $445.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $730.00K 10-Q · filed 2018-08-01 | $1.09M derived: sum of 3 quarters · filed 2019-02-20 | $1.25M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-03-31 | $285.00K 10-Q · filed 2018-05-02 | $645.00K derived: sum of 2 quarters · filed 2019-02-20 | $809.00K derived: sum of 3 quarters · filed 2019-02-20 | $1.13M derived: sum of 4 quarters · filed 2019-02-20 |
| 2016-12-31 | $360.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $524.00K derived: sum of 2 quarters · filed 2019-02-20 | $845.00K derived: sum of 3 quarters · filed 2019-02-20 | $1.34M 10-K · filed 2019-02-20 |
| 2016-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $485.00K derived: sum of 2 quarters · filed 2017-11-02 | $982.00K 10-Q · filed 2017-11-02 | $1.27M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $818.00K 10-Q · filed 2017-08-01 | $1.10M derived: sum of 3 quarters · filed 2018-02-26 | $1.71M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $497.00K 10-Q · filed 2017-05-02 | $783.00K derived: sum of 2 quarters · filed 2018-02-26 | $1.39M derived: sum of 3 quarters · filed 2018-02-26 | $1.68M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $892.00K derived: sum of 2 quarters · filed 2018-02-26 | $1.18M derived: sum of 3 quarters · filed 2018-02-26 | $1.36M 10-K · filed 2018-02-26 |
| 2015-09-30 | $606.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $893.00K derived: sum of 2 quarters · filed 2016-11-01 | $1.07M 10-Q · filed 2016-11-01 | $1.14M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $467.00K 10-Q · filed 2016-08-04 | $531.00K derived: sum of 3 quarters · filed 2017-02-23 | $1.17M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $180.00K 10-Q · filed 2016-05-03 | $244.00K derived: sum of 2 quarters · filed 2017-02-23 | $883.00K derived: sum of 3 quarters · filed 2017-02-23 | |
| 2014-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $703.00K derived: sum of 2 quarters · filed 2017-02-23 | $1.59M 10-K · filed 2017-02-23 | |
| 2014-09-30 | $639.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $1.53M 10-Q · filed 2015-11-04 | ||
| 2014-06-30 | $890.00K 10-Q · filed 2015-08-05 | |||
| 2013-12-31 | $4.85M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |